Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CTH | P32929 | 1/20 | 0.30 |
| ▸ | CBS | P35520 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30841598 | 1.00 | EPHX2 (0.30) | EPHX2TSHRCTHCBSTHPO | |
| SCHEMBL31519000 | 0.82 | ALDH1A1 (0.39) | TSHR | |
| SCHEMBL31064869 | 0.82 | ALDH1A1 (0.39) | TSHR | |
| SCHEMBL31629201 | 0.82 | ALDH1A1 (0.39) | TSHR | |
| SCHEMBL6317524 | 0.81 | KDM4E (0.35) | EPHX2 | |
| SCHEMBL9610844 | 0.79 | EPHX2 (0.38) | EPHX2TSHRCTHCBSTHPO | |
| SCHEMBL24984051 | 0.79 | TSHR (0.40) | TSHR | |
| SCHEMBL30521530 | 0.79 | EGLN1 (0.39) | TSHRCTH | |
| SCHEMBL30629028 | 0.74 | — | — | |
| SCHEMBL8656284 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661913-A1 | SELF-STABILIZING LINKER CONJUGATES | Beone Medicines I GmbH (CH) | 2025-12-17 | — | — | EP | disclosed |
| EP-4661912-A1 | LINKER FOR ANTIBODY-DRUG CONJUGATE | Pinotbio, Inc. (KR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250352659-A1 | SELF-STABILIZING LINKER CONJUGATES | BEONE MEDICINES I GMBH (CH) | 2025-11-20 | — | — | US | disclosed |
| EP-4536666-A1 | ANTIBODY DRUG CONJUGATES | BeiGene, Ltd. (KY) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025032555-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | BEIGENE SWITZERLAND GMBH (CH) | 2025-02-13 | — | — | WO | disclosed |
| WO-2024165045-A1 | SELF-STABILIZING LINKER CONJUGATES | BEIGENE, LTD. (KY) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024166056-A1 | LINKER FOR ANTIBODY-DRUG CONJUGATE | PINOTBIO, INC. (KR) | 2024-08-15 | — | — | WO | disclosed |
| WO-2023237050-A1 | ANTIBODY DRUG CONJUGATES | BEIGENE, LTD. (KY) | 2023-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352659-A1 | SELF-STABILIZING LINKER CONJUGATES | H1-0, MAPT, FCGRT | EPHX2 2848/4885TSHR 164/4885CTH 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.